| Literature DB >> 28253292 |
Takuro Furusawa1, Izumi Naka2, Taro Yamauchi3, Kazumi Natsuhara4, Ricky Eddie5, Ryosuke Kimura6, Minato Nakazawa7, Takafumi Ishida2, Ryutaro Ohtsuka8, Jun Ohashi2.
Abstract
The people of the Solomon Islands represent an Austronesian (AN)-speaking population's adaptation to a humid tropical environment and subsistence of tuberous crops. Genome-wide association studies (GWASs) of other populations (e.g. the Human Genome Diversity Project [HGDP]) have suggested the existence of genotypes adaptive to ecoregion, diet, and subsistence, and that those genotypes are also associated with metabolic and cardiovascular diseases. Recently, the incidence of non-communicable diseases has been increasing in the Solomon Islands. In the present study, we explored the association of genotypes adaptive to a tropical environment and tuberous crop diet with metabolic and cardiovascular conditions in rural and urban AN-speaking Melanesian and Micronesian populations of the Solomon Islands. A total of 561 participants were genotyped for single nucleotide polymorphisms (SNPs) potentially associated with a tropical environment (rs174570 and rs2237892) and a tuberous crop diet (rs162036, rs185819, and rs2722425). The results showed that the allele frequencies of the Solomon Islands populations adopted patterns similar to those in populations from other hot, tropical areas with a tuberous crop diet in previous studies. Furthermore, rs162036, rs185819, rs2237892, and rs2722425 were all strongly associated with one or more metabolic and cardiovascular conditions. The derived allele of rs2722425 (i.e. rs2722425-G) was significantly associated with an elevated LDL level (P = 0.000264) even after the significance level was adjusted for multiple testing (i.e., α = 0.0005). Our results suggest that the inhabitants of the Solomon Islands exhibit the effects of the tropical environment and tuberous crop diet on their allele frequencies, and that their susceptibility to metabolic and cardiovascular diseases is therefore considered to be associated with their environment and diet.Entities:
Mesh:
Year: 2017 PMID: 28253292 PMCID: PMC5333831 DOI: 10.1371/journal.pone.0172676
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1The allele frequencies of five SNPs in populations analyzed in the Human Genome Diversity Project (HGDP) and in this study.
This study analyzed the Kusaghe (rural Melanesian, N = 183), Munda (urban Melanesian, N = 215), and Ravaki peoples (Micronesian, N = 163); Ravaki people were sampled from the Solomon Islands, and their original location is shown on the map. HGDP East Asia (N = 234) includes the following geographic origins: China, Japan, Siberia; HGDP Europe (N = 160): France, Italy, Italy (Bergamo), Orkney Islands, Russia, Russia (Caucasus); HGDP Melanesia (N = 36): Bougainville, Papua New Guinea, HGDP Middle East (N = 146): Israel (Carmel), Israel (Central), Israel (Negev); HGDP North Africa (N = 30): Algeria (Mzab); HGDP Latin America (N = 108): Brazil, Colombia, and Mexico; HGDP South Asia (N = 197): Pakistan; HGDP Southeast Asia (N = 11): Cambodia; and HGDP Sub-Saharan Africa (N = 121): Central African Republic, Democratic Republic of Congo, Kenya, Namibia, Nigeria, Senegal, and South Africa.
Characteristics of study participants, broken down by populations.
| Kusaghe (Rural, Melanesian) N = 215 | Munda (Urban, Melanesian) N = 183 | Ravaki (Peri-urban, Micronesian) N = 153 | ||
|---|---|---|---|---|
| Gender (% male) | 106:109 (49.3%) | 91:95 (48.9%) | 57:61 (48.3%) | |
| Age (years) | 37.17 ± 0.93 | 45.43 ± 1.06 | 34.62 ± 1.21 | |
| Body height (cm) | 159.23 ± 0.47 | 159.60 ± 0.55 | 165.27 ± 0.77 | |
| Body weight (kg) | 60.97 ± 0.49 | 65.88 ± 1.01 | 79.13 ± 1.51 | |
| BMI (kg/m2) | 24.06 ± 0.18 | 25.84 ± 0.37 | 28.96 ± 0.51 | |
| SBP (mmHg) | 119.38 ± 0.97 | 127.13 ± 1.56 | 117.20 ± 1.26 | |
| DBP (mmHg) | 71.16 ± 0.64 | 79.22 ± 0.90 | 76.32 ± 0.96 | |
| Total cholesterol (mg/dL) | 179.63 ± 2.37 | 185.85 ± 2.74 | 166.17 ± 3.50 | |
| LDL (mg/dL) | 113.73 ± 2.05 | 126.22 ± 2.43 | 114.64 ± 3.14 | |
| HDL (mg/dL) | 51.08 ± 0.76 | 43.56 ± 0.76 | 39.84 ± 0.88 | |
| Glucose (mg/dL) | 94.54 ± 2.67 | 94.86 ± 1.47 | 98.45 ± 2.84 | |
| Leptin (mg/dL) | 6.86 ± 0.44 | 13.52 ± 1.00 | 10.73 ± 0.83 | |
| Obesity (BMI ≥ 30 kg/m2) | 2.4% | 18.6% | 30.1% | |
| Hypertension (SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg) | 8.6% | 23.0% | 12.3% | |
| Diabetes (glucose ≥ 110 mg/dl) | 7.0% | 8.1% | 17.8% | |
| High total cholesterol (cholesterol ≥ 240 mg/dl) | 5.1% | 8.1% | 1.7% | |
| High LDL (LDL ≥ 140 mg/dl) | 18.6% | 29.2% | 22.9% | |
| Allele Frequencies | ||||
| Rs162036 | AA | 41.4% | 58.5% | 70.1% |
| AG | 49.8% | 36.6% | 28.8% | |
| GG | 8.8% | 4.9% | 2.4% | |
| Rs174570 | CC | 7.0% | 9.3% | 18.9% |
| CT | 36.7% | 47.5% | 54.3% | |
| TT | 56.3% | 43.2% | 26.2% | |
| Rs185819 | CC | 27.9% | 29.5% | 7.9% |
| CT | 51.2% | 54.1% | 25.0% | |
| TT | 20.9% | 16.4% | 66.5% | |
| Rs2237892 | CC | 48.4% | 30.6% | 44.5% |
| CT | 40.9% | 50.8% | 41.5% | |
| TT | 10.7% | 18.6% | 14.0% | |
| Rs2722425 | GG | 62.8% | 66.1% | 43.9% |
| GA | 35.3% | 30.6% | 47.0% | |
| AA | 1.9% | 3.3% | 9.1% | |
BMI, body mass index; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure.
The effects of tropical-climate-related SNPs and root-crop-diet-related SNPs on health indicators; general linear model, after adjustment for age, gender, and population differences (also see S2–S6 Tables).
| rs162036 | rs174570 | rs185819 | rs2237892 | rs2722425 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Body height (cm) | AA vs. AG | − 0.20 (0.51) NS | CC vs. CT | 1.09 (0.79) NS | CC vs. CT | 0.77 (0.62) NS | CC vs. CT | 0.75 (0.52) NS | GG vs. GA | − 0.43 (0.51) NS |
| AA vs. GG | − 0.71 (1.04) NS | CC vs. TT | 1.11 (0.82) NS | CC vs. TT | 0.11 (0.75) NS | CC vs. TT | 1.62 (0.74) | GG vs. AA | − 0.37 (1.20) NS | |
| Body weight (kg) | AA vs. AG | 2.00 (1.15) NS | CC vs. CT | 0.54 (1.80) NS | CC vs. CT | 1.59 (1.40) NS | CC vs. CT | 1.54 (1.17) NS | GG vs. GA | 0.23 (1.15) NS |
| AA vs. GG | − 3.06 (2.33) NS | CC vs. TT | 1.28 (1.86) NS | CC vs. TT | 2.97 (1.70) NS 0 | CC vs. TT | 2.69 (1.68) NS | GG vs. AA | − 0.63 (2.71) NS | |
| BMI (kg/m2) | AA vs. AG | 0.80 (0.40) | CC vs. CT | − 0.13 (0.62) NS | CC vs. CT | 0.38 (0.48) NS | CC vs. CT | 0.29 (0.41) NS | GG vs. GA | 0.19 (0.40) NS |
| AA vs. GG | − 1.06 (0.81) NS | CC vs. TT | 0.11 (0.64) NS | CC vs. TT | 1.21 (0.59) | CC vs. TT | 0.45 (0.58) NS | GG vs. AA | − 0.16 (0.94) NS | |
| SBP (mmHg) | AA vs. AG | 4.48 (1.49) | CC vs. CT | 0.35 (2.34) NS | CC vs. CT | − 0.84 (1.83) NS | CC vs. CT | 0.29 (1.52) NS | GG vs. GA | 2.48 (1.49) NS |
| AA vs. GG | − 1.35 (3.00) NS | CC vs. TT | − 1.41 (2.42) NS | CC vs. TT | 0.95 (2.21) NS | CC vs. TT | 3.93 (2.16) NS | GG vs. AA | 6.07 (3.49) NS | |
| DBP (mmHg) | AA vs. AG | 1.66 (0.96) NS | CC vs. CT | − 1.14 (1.50) NS | CC vs. CT | 0.00 (1.17) NS | CC vs. CT | 1.18 (0.97) NS | GG vs. GA | 1.00 (0.95) NS |
| AA vs. GG | − 1.75 (1.93) NS | CC vs. TT | − 1.98 (1.55) NS | CC vs. TT | 0.83 (1.41) NS | CC vs. TT | 3.20 (1.38) | GG vs. AA | 3.91 (2.24) NS | |
| Total cholesterol (mg/dL) | AA vs. AG | 1.30 (3.10) NS | CC vs. CT | 0.26 (4.81) NS | CC vs. CT | − 0.68 (3.75 NS) | CC vs. CT | 0.28 (3.14) NS | GG vs. GA | 10.44 (3.04) |
| AA vs. GG | 2.65 (6.29) NS | CC vs. TT | 3.36 (4.97 NS | CC vs. TT | − 9.39 (4.55) | CC vs. TT | 5.36 (4.50) NS | GG vs. AA | 14.36 (7.18) | |
| LDL (mg/dL) | AA vs. AG | − 0.43 (2.77) NS | CC vs. CT | − 0.30 (4.30) NS | CC vs. CT | − 0.90 (3.35) NS | CC vs. CT | − 1.45 (2.81) NS | GG vs. GA | 9.98 (2.72) |
| AA vs. GG | 1.50 (5.61) NS | CC vs. TT | 1.68 (4.44) NS | CC vs. TT | − 8.04 (4.06) | CC vs. TT | 3.36 (4.02) NS | GG vs. AA | 10.48 (6.41) NS | |
| HDL (mg/dL) | AA vs. AG | 1.63 (0.94) NS | CC vs. CT | 1.18 (1.47) NS | CC vs. CT | 1.21 (1.15) NS | CC vs. CT | 1.59 (0.96) NS | GG vs. GA | − 0.55 (0.94) NS |
| AA vs. GG | 1.89 (1.91) NS | CC vs. TT | 2.10 (1.51) NS | CC vs. TT | 1.28 (1.39) NS | CC vs. TT | 1.08 (1.37) NS | GG vs. AA | 0.23 (2.22) NS | |
| Glucose (mg/dL) | AA vs. AG | − 3.54 (2.88) NS | CC vs. CT | − 0.32 (4.47) NS | CC vs. CT | − 5.03 (3.50) NS | CC vs. CT | 0.071 (2.932) NS | GG vs. GA | − 1.43 (2.87) NS |
| AA vs. GG | − 6.22 (5.85) NS | CC vs. TT | − 6.38 (4.62) NS | CC vs. TT | − 10.06 (4.24) | CC vs. TT | − 2.83 (4.20) NS | GG vs. AA | − 4.25 (6.78) NS | |
| Leptin (mg/dL) | AA vs. AG | 0.85 (0.77) NS | CC vs. CT | − 0.56 (1.20) NS | CC vs. CT | 1.67 (0.94) NS | CC vs. CT | 0.42 (0.79) NS | GG vs. GA | − 0.76 (0.77) NS |
| AA vs. GG | − 1.24 (1.57) NS | CC vs. TT | 0.24 (1.24) NS | CC vs. TT | 2.60 (1.14) | CC vs. TT | 0.34 (1.12) NS | GG vs. AA | − 0.11 (1.82) NS | |
HDL, high-density lipoprotein; LDL, low-density lipoprotein.
The effects of tropical-climate-related SNPs and root-crop-diet-related SNPs on the occurrence of diseases; logistic regression analyses, after adjustment for age, gender, and population differences (also see S9–S13 Tables).
| rs162036 | rs174570 | rs185819 | rs2237892 | rs2722425 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Overweight (BMI ≥25 kg/m2) | AA vs. AG | 1.36 [0.90–2.06] NS | CC vs. CT | 0.74 [0.38–1.41] NS | CC vs. CT | 1.08 [0.66–1.77] NS | CC vs. CT | 0.94 [0.62–1.43] NS | GG vs. GA | 0.79 [0.52–1.19] NS |
| AA vs. GG | 0.43 [0.16–1.05] NS | CC vs. TT | 0.78 [0.40–1.51] NS | CC vs. TT | 1.73 [0.96–3.13] NS | CC vs. TT | 1.40 [0.77–2.57] NS | GG vs. AA | 0.41 [0.15–1.09] NS | |
| Diabetes (serum glucose ≥110 mg/dL | AA vs. AG | 0.99 [0.94–1.05] NS | CC vs. CT | 1.01 [0.93–1.10] NS | CC vs. CT | 0.98 [0.92–1.05] NS | CC vs. CT | 0.97 [0.92–1.02] NS | GG vs. GA | 0.99 [0.94–1.05] NS |
| AA vs. GG | 0.98 [0.88–1.08] NS | CC vs. TT | 0.97 [0.89–1.05] NS | CC vs. TT | 0.96 [0.89–1.04] NS | CC vs. TT | 0.95 [0.88–1.03] NS | GG vs. AA | 0.99 [0.87–1.12] NS | |
| Hypertension (SBP ≥140 mmHg and/or DBP ≥90 mmHg) | AA vs. AG | 1.06 [0.999–1.13] NS | CC vs. CT | 0.94 [0.85–1.04] NS | CC vs. CT | 0.95 [0.88–1.03] NS | CC vs. CT | 1.05 [0.98–1.12] NS | GG vs. GA | 1.02 [0.96–1.09] NS |
| AA vs. GG | 0.99 [0.87–1.12] NS | CC vs. TT | 0.90 [0.81–0.997] | CC vs. TT | 1.01 [0.92–1.11] NS | CC vs. TT | 1.05 [0.96–1.15] NS | GG vs. AA | 1.12 [0.96–1.29] NS | |
| High cholesterol (serum chorlesterol≥240 mg/dL) | AA vs. AG | 0.99 [0.95–1.04] NS | CC vs. CT | 1.00 [0.94–1.07] NS | CC vs. CT | 1.04 [0.99–1.10] NS | CC vs. CT | 0.99 [0.95–1.04] NS | GG vs. GA | 1.05 [1.01–1.10] |
| AA vs. GG | 1.00 [0.92–1.09] NS | CC vs. TT | 1.03 [0.96–1.10] NS | CC vs. TT | 0.99 [0.94–1.06] NS | CC vs. TT | 1.05 [0.99–1.12] NS | GG vs. AA | 1.08 [0.98–1.19] NS | |
| High LDL (serum LDL ≥140 mg/dL) | AA vs. AG | 0.99 [0.92–1.06] NS | CC vs. CT | 1.04 [0.93–1.17] NS | CC vs. CT | 0.97 [0.88–1.06] NS | CC vs. CT | 0.99 [0.92–1.07] NS | GG vs. GA | 1.12 [1.04–1.20] |
| AA vs. GG | 1.00 [0.86–1.16] NS | CC vs. TT | 1.05 [0.93–1.18] NS | CC vs. TT | 0.93 [0.83–1.03] NS | CC vs. TT | 1.05 [0.94–1.17] NS | GG vs. AA | 1.07 [0.90–1.27] NS | |
BMI, body mass index; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure.